Cargando…
Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses
Severe emerging and re-emerging viral infections such as Lassa fever, Avian influenza (AI), and COVID-19 caused by SARS-CoV-2 urgently call for new strategies for the development of broad-spectrum antivirals targeting conserved components in the virus life cycle. Viral lipids are essential component...
Autores principales: | Lu, Shengsheng, Pan, Xiaoyan, Chen, Daiwei, Xie, Xi, Wu, Yan, Shang, Weijuan, Jiang, Xiaming, Sun, Yuan, Fan, Sheng, He, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784547/ https://www.ncbi.nlm.nih.gov/pubmed/33450541 http://dx.doi.org/10.1016/j.bioorg.2020.104619 |
Ejemplares similares
-
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019) -
Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019) -
A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer
por: Zhang, Da-Wei, et al.
Publicado: (2022) -
Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020) -
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)